President’s Welcome Message
Dear Colleagues and Friends,
It is my great pleasure to welcome you to the 3rd Annual Meeting of the International Myopia Society, to be held in the heart of Tokyo at the Suzuki Akio Memorial Hall, Institute of Science Tokyo—conveniently located just across from Ochanomizu Station.
This year’s meeting will be held in conjunction with the 8th Annual Meeting of the Japan Myopia Society (June 20–21), together forming Myopia Week 2026.
The International Myopia Society was established just two years ago, and since then, we have held two highly successful meetings—our inaugural meeting in Paris, in collaboration with the French Myopia Institute and with support from EURETINA, and our second meeting in Singapore, which featured a dynamic consensus session and cutting-edge presentations by both international and local faculty.
The 3rd Annual Meeting will continue this tradition, featuring lectures and consensus sessions led by leading global experts. Myopia is a multifaceted field, encompassing pediatric care, complications, basic science, epidemiology, genetics, pharmacology, novel optical treatments, orthokeratology, and red-light therapy. Our aim is to bring together ophthalmologists, orthoptists, optometrists, researchers, and industry partners to foster rich, interdisciplinary dialogue and collaboration.
In recent years, we’ve witnessed remarkable innovation in pediatric myopia management, with numerous new drugs and devices introduced by companies around the world. To reflect this momentum, the program will include industry-led presentations and an exhibition showcasing cutting-edge technologies—including some not yet approved in Japan—offering attendees a unique opportunity to explore the forefront of global myopia care.
We are also planning engaging social events featuring exceptional cuisine, offering opportunities for informal exchange and a taste of Tokyo’s renowned hospitality.
Participants may register for the International Myopia Society Meeting alone, or select a Myopia Week Package that includes full access to both meetings.
We warmly invite your participation and are confident this gathering will be both impactful and memorable.
I very much look forward to welcoming you to Tokyo in June 2026.
Warmest regards,
International Myopia Society
Executive Committee
Aude Couturier
France
Gemmy Cheung
Singapore
Kyoko Ohno-Matsui
Japan
Richard Spaide
USA
Invited faculty
Audrey Chia Wei Lin
Singapore
Rachel Chong
Singapore
Ian Flitcroft
Ireland
Li Lian Foo
Singapore
Mingguang He
Hong Kong
Zi-Bin Jing
China
Jost Jonas
Germany
Chi-Chun Lai
Taiwan
Timothy Lai
Hong Kong
Weizhong Lan
China
Shu Yen Lee
Singapore
Kiho Park
South Korea
Serge Resnikoff
Australia
Jose Maria Ruiz-Moreno
Spain
Seang Mei Saw
Singapore
Gavin Tan
Singapore
Yaxing Wang
China
Tien Yin Wong
China
Pei-Chang Wu
Taiwan
Jason Yam
Hong Kong
Xiulan Zhang
China
Marcus Ang
Singapore
Program & Call for Abstracts
Preliminary Program
Session 1 (epidemiology)
- Serge Resnikoff
- “Lessons learned from recent epidemiological data on myopia”
- Yaxing Wang
- “Natural History Study of Myopia”
- Pei-Chang Wu
- “The public health approach to decrease the myopia and high myopia prevalence in Taiwan”
- Seang Mei Saw
- “The pattern of pathologic myopia in adults in prospective community cohorts”
Session 2 (etiology and AI)
- Jost Jonas
- “Puzzling over morphological features of myopia to understand its etiology”
- Weizhong Lan
- “Spatial frequency and Myopia: Evidence from Clinical Trials”
- Zi-Bin Jing
- “High Myopia: from genetics to therapeutic development”
- Marcus Ang
- “AI in Myopia”
- Tien Yin Wong
- “Current Challenges of AI in Medicine: Lessons for the Myopia Community”
- Ian Flitcroft
- “Anatomical Equivalent Refraction: an AI framework for managing and monitoring myopia-related vision impairment risks in children and adults”
Session 3 (prevention)
- Foo Li Lian
- “Which Therapy Holds the Key to the Future of Childhood Myopia Management?”
- Jason Yam
- “Cost-effectiveness analysis of myopia control interventions”
- Mingguang He
- “Low level red-light therapy for myopia”
- Audrey Chia Wei Lin
- “Pre-myopia: insights from ATOM3”
Session 4 (medical retina)
- Aude Couturier
- “Characterization and progression of Myopic Chorioretinal Atrophy in a French Cohort”
- Timothy Lai
- “Management of myopic macular neovascularization”
- Gemmy Cheung
- “Role of inflammation in myopic degeneration”
- Jose Maria Ruiz-Moreno
- “Clinical implications of posterior staphyloma in high myopic eyes”
- Kyoko Ohno-Matsui
- “Polarization-sensitive imaging of peripapillary sclera”
Session 5 (surgical retina)
- Richard Spaide
- “New Imaging of the Vitreous in High Myopia”
- Shu Yen Lee
- “Peripheral retinal changes and retinal detachments in young myopic adults (tentative)”
- Gavin Tan
- “Surgery for myopic tractional maculopathy: vitrectomy and or macular buckle?”
- Chi-Chun Lai
- “Macular Hole Closure Patterns after Macular Hole Retinal Detachment Surgery in Highly Myopic Eyes”
Session 6 (glaucoma)
- Ki Ho Park
- “Which patients are at risk of progression in myopic glaucoma?”
- Xiulan Zhang
- “Differentiating Glaucomatous and Myopic Optic Neuropathy with Optical Coherence Tomography”
- Rachel Chong
- “Associations between Intraocular Pressure and Pathologic Myopia Incidence and Progression”
Free Paper Submission starts on December 1st. 2025.
Deadline January 31st. 2026.
The Myopia Week 2026 welcomes high-quality abstracts on original research and innovative clinical/educational initiatives related to myopia.
Abstracts should clearly describe the purpose, methods, findings, and significance of the work. Both quantitative and qualitative studies, as well as technology-based and clinical investigations, are encouraged.
Registration
TBA